Coherent Corp. enters the first week of June with the most dramatic single-session move in recent memory — a 17.6% gain on June 2 that has reset the conversation entirely.
The scale of Tuesday's move changes what's worth watching. The stock closed at $426.89, up nearly 12% on the week and 30% over the past month. That kind of run puts the stock above most Street targets published as recently as early May, and it forces a reassessment of where positioning now sits relative to those anchor prices. The last trader note flagged a softening options hedge and a slow short-side retreat — both of those dynamics have now been overtaken by the size of the move itself.
Short interest tells a more complicated story this week. Bears had been quietly rebuilding through late May — SI climbed 8.5% over the week to 5.37% of the free float, reversing the month-long grind lower that had taken it from above 9.3 million shares in late April down to the low-7 million range by mid-May. At 8.44 million shares short, it's still well below the April peak, but the week-on-week direction has flipped. The borrow market remains entirely unthreatening: cost to borrow is 0.42% annually, cheap despite a 17% rise on the week, and availability is extraordinarily loose at 3,828% — meaning roughly 38 shares are available to borrow for every one currently lent out. There is no squeeze pressure in the lending market whatsoever. The rebuilding short is likely tactical hedging against the move rather than a structural bear thesis.
Options positioning has drifted back toward defensive territory, though without the alarm that would warrant calling it a crowded hedge. The put/call ratio reached a 52-week high of 1.2025 on May 29, before settling to 1.17 by June 2. That's about one standard deviation above the 20-day average of 1.10 — a mild lean toward protection, but far from the kind of extreme reading that would signal deep institutional concern. With the next confirmed earnings date not until August 14, the hedging is most plausibly read as traders buying downside insurance against a stock that has just moved 30% in a month, rather than any event-driven positioning.
The Street came into the week already stretched in the bull direction, and Tuesday's print pushed the stock above several recently-raised targets. Ahead of the May 6 earnings print, TD Cowen lifted to $395, Rosenblatt to $425, Stifel to $412, and Citigroup had already moved to $420 in late April. The consensus mean target now sits at $380.61 — meaning the stock has run through the average analyst target on the back of a single session. Morgan Stanley remains the skeptic, holding an Equal-Weight rating with a $290 target. JP Morgan's Overweight carry a $300 handle. The bull case centers on vertical integration, improving gross margins, Indium Phosphide capacity expansion, and strong backlog. The bear case points to macro and tariff exposure, communications-market concentration, and the risk that the industrial segment's early-stage growth disappoints. On valuation, the stock now trades at 65x trailing earnings and 44.7x EV/EBITDA — multiples that have expanded sharply, with the PE ratio up over 11 points in the past 30 days alone.
Institutional holders have been building, not trimming: FMR added 560K shares to reach 11.4% of outstanding, BlackRock added 485K, and State Street added 3 million in the most recent reported period. That underlying bid from large passive and active managers is supportive context for the run. Insider activity is a mild counterpoint — CFO Sherri Luther sold 2,000 shares at $373 on May 12, and independent director Howard Xia has been selling in tranches since March — but at significance scores of 2 out of 10 and involving tiny fractions of total shares, these reads more like routine programme sales than signals of conviction.
What to watch next is whether the Street catches up to the move: the spread between the current price and the consensus target is now inverted, and the next wave of analyst revisions — likely triggered by the post-June 2 close — will clarify whether the bullish firms follow Rosenblatt to $425-plus territory or whether the gap between price and target becomes a ceiling that draws more defensive positioning into August earnings.
See the live data behind this article on ORTEX.
Open COHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
